Buscar
Mostrando ítems 71-74 de 74
Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece
(2015)
Objectives: Visceral leishmaniasis (VL) is re-emerging in endemic areas. The epidemiological, clinical, laboratory, and treatment outcome characteristics in a large cohort of VL patients is described herein. Methods: The ...
Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease
(2014)
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and can progress to cirrhosis, liver failure, and hepatocellular carcinoma. In the last two decades, the prevalence of NAFLD has ...
Metabolic Acidosis during Treatment of Mushroom Poisoning: A Diagnostic Pitfall
(2012)
Metabolic acidosis is a frequently encountered acid-base disturbance in hospitalized patients that occasionally develops in the course of treatment with medications used in everyday clinical practice, including propylene ...
Early primary biliary cirrhosis: A new association with erythema nodosum of unknown origin
(2010)
Primary biliary cirrhosis (PBC) is associated with immune-mediated dermatologic disorders. The association of PBC with erythema nodosum (EN) seems rare. We report two females (42 and 44 years old) with low-grade fever, ...